Mathematical modeling of molecular data in translational medicine: Theoretical considerations

Science Translational Medicine

Volumn 2, Issue 56, 2010, Pages

  Marko, Nicholas F ^a   Weil, Robert J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ANALYTIC METHOD; ARTIFICIAL INTELLIGENCE; CLINICAL MEDICINE; DATA BASE; LEARNING; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; PREDICTION; PRIORITY JOURNAL; PROBABILITY; REVIEW; STATISTICAL ANALYSIS; THEORY; TRANSLATIONAL RESEARCH; COMPUTER SIMULATION; HUMAN; MEDICINE; SYSTEM ANALYSIS; THEORETICAL MODEL;

COMPUTER SIMULATION; HUMANS; MEDICINE; MODELS, THEORETICAL; PROBABILITY THEORY; TRANSLATIONAL RESEARCH;

EID: 78149343523     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3001207     Document Type: Review

References (80)

1. J. Quackenbush, Microarray analysis and tumor classification. N. Engl. J. Med. 354, 2463-2472 (2006).
2. S. Albani, B. Prakken, The advancement of translational medicine - from regional challenges to global solutions. Nat. Med. 15, 1006-1009 (2009).
3. B. H. Littman, L. Di Mario, M. Plebani, F. M. Marincola, What's next in translational medicine? Clin. Sci. 112, 217-227 (2007).
4. N. P. Paynter, D. I. Chasman, G. Paré, J. E. Buring, N. R. Cook, J. P. Miletich, P. M. Ridker, Association between a literature-based genetic risk score and cardiovascular events in women. JAMA 303, 631-637 (2010).
5. J. D. Storey, R. Tibshirani, Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. U.S.A. 100, 9440-9445 (2003).
6. J. K. Lee, P. D. Williams, S. Cheon, Data mining in genomics. Clin. Lab. Med. 28, 145-166 (2008).
7. B. A. Ogunnaike, C. A. Gelmi, J. S. Edwards, A probabilistic framework for microarray data analysis: Fundamental probability models and statistical inference. J. Theor. Biol. 264, 211-222 (2010).
8. Y. Ge, S. C. Sealfon, T. P. Speed, Multiple testing and its applications to microarrays. Stat. Methods Med. Res. 18, 543-563 (2009).
9. T. P.Speed, Statistical Analysis of Gene Expression Microarray Data (Chapman & Hall/CRC, Boca Raton, FL, 2003).
10. Student, The probable error of a mean. Biometrika 6, 1-25 (1908).
11. Z. Šidák, Rectangular confidence regions for the means of multivariate normal distributions. J. Am. Stat. Assoc. 62, 626-633 (1967).
12. C. Bonferroni, Teoria Statistica delle classi e calcolo delle probabilità. Pubbl. R Ist. Super. Sci. Econ. Comm. Firenze 8, 3-62 (1936).
13. Y. Benjamini, D. Yekutieli, The control of the false discovery rate in multiple testing under dependency. Ann. Stat. 29, 1165-1188 (2001).
14. E. L. Lehmann, J. P. Romano, Generalization of the familywise error rate. Ann. Stat. 33, 1138-1154 (2005).
15. J. P. Romano, A. M. Shaikh, Stepup procedures for control of generalizations of the familywise error rate. Ann. Stat. 34, 1850-1873 (2006).
16. V. G. Tusher, R. Tibshirani, G. Chu, Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U.S.A. 98, 5116-5121 (2001).
17. M. M. Meerschaert, Mathematical Modeling (Elsevier/Academic Press, Boston, ed. 3, 2007).
18. P. Eykhoff, System Identification: Parameter and State Estimation (Wiley-Interscience, New York, 1974).
19. J. V. Leonard, Komrower lecture: Treatment of inborn errors of metabolism: A review. J. Inherit. Metab. Dis. 29, 275-278 (2006).
20. S. P. Mankoff, C. Brander, S. Ferrone, F. M. Marincola, Lost in translation: Obstacles to translational medicine. J. Transl. Med. 2, 14 (2004).
21. M. E. J. Lean, J. I. Mann, J. A.Hoek, R. M. Elliot, G. Schofield, Translational research: From evidence based medicine to sustainable solutions for public health problems. BMJ 337, a863 (2008).
22. K. E. James, R. F. White, H. C. Kraemer, Repeated split sample validation to assess logistic regression and recursive partitioning: An application to the prediction of cognitive impairment. Stat. Med. 24, 3019-3035 (2005).
23. P. Royston, D. G. Altman, W. Sauerbrei, Dichotomizing continuous predictors in multiple regression: A bad idea. Stat. Med. 25, 127-141 (2006).
24. R. C. MacCallum, S. Zhang, K. J. Preacher, D. D. Rucker, On the practice of dichotomization of quantitative variables. Psychol. Methods 7, 19-40 (2002).
25. D. G. Altman, P. Royston, The cost of dichotomising continuous variables. BMJ 332, 1080 (2006).
26. D. Faraggi, R. Simon, A simulation study of cross-validation for selecting an optimal cutpoint in univariate survival analysis. Stat. Med. 15, 2203-2213 (1996).
27. P. C. Austin, L. J. Brunner, Inflation of the type I error rate when a continuous confounding variable is categorized in logistic regression analyses. Stat. Med. 23, 1159-1178 (2004).
28. J. R. Irwin, G. H. McClelland, Negative consequences of dichotomizing continuous predictor variables. J. Mark. Res. 40, 366-371 (2003).
29. D. G. Altman, B. Lausen, W. Sauerbrei, M. Schumacher, Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J. Natl. Cancer Inst. 86, 829-835 (1994).
30. J. W. Lee, S. H. Um, J. B. Lee, J. Mun, H. Cho, Scoring and staging systems using Cox linear regression modeling and recursive partitioning. Methods Inf. Med. 45, 37-43 (2006).
31. A. Ruvinsky, Genetics and Randomness (CRC Press, Boca Raton, FL, 2010).
32. S. Kaski, J. Rousu, E. Ukkonen, Probabilistic modeling and machine learning in structural and systems biology. BMC Bioinformatics 8, S1 (2007).
33. N. Friedman, Inferring cellular networks using probabilistic graphical models. Science 303, 799-805 (2004).
34. G. F. Lawler, Introduction to Stochastic Processes (Chapman & Hall/CRC, Boca Raton, FL, ed. 2, 2006).
35. J. R. Thompson, Simulation-based estimation of stochastic process parameters in tumor growth. C. R. Biol. 327, 181-192 (2004).
36. R. B. Schinazi, A stochastic model for cancer risk. Genetics 174, 545-547 (2006).
37. American Joint Committee on Cancer, AJCC Cancer Staging Handbook (Springer, New York, 2009).
38. X. Zhao, L. W. Cheung, Kernel-imbedded Gaussian processes for disease classification using microarray gene expression data. BMC Bioinformatics 8, 67 (2007).
39. D. Keysers, H. Ney, Linear discriminant analysis and discriminative log-linear modeling, in Proceedings of the 17th International Conference on Pattern Recognition, Cambridge, UK, 23 to 26 August 2004 (IEEE Computer Society Press, Los Alamitos, CA, 2004), vol. 1, pp. 156-159.
40. S. Raychaudhuri, J. M. Stuart, R. B. Altman, Principal components analysis to summarize microarray experiments: Application to sporulation time series. Pac. Symp. Biocomput. 455-466 (2000).
41. W. Kong, C. R. Vanderburg, H. Gunshin, J. T. Rogers, X. Huang, A review of independent component analysis application tomicroarray gene expression data. Biotechniques 45, 501-520 (2008).
42. S. R. Eddy, What is a hidden Markov model? Nat. Biotechnol. 22, 1315-1316 (2004).
43. B. Vogelstein, K. W. Kinzler, Cancer genes and the pathways they control. Nat. Med. 10, 789-799 (2004).
44. C. M. Chen, C. Lee, C. L. Chuang, C. C. Wang, G. S. Shieh, Inferring genetic interactions via a nonlinear model and an optimization algorithm. BMC Syst. Biol. 4, 16 (2010).
45. B. Shahbaba, A. J. Gentles, J. Beyene, S. K. Plevritis, C. M. T. Greenwood, A Bayesian non-parametric method for model evaluation: Application to genetic studies. J. Nonparametr. Stat. 21, 379-396 (2009).
46. K.-A. Do, P. Müller, M. Vannucci, Bayesian Inference for Gene Expression and Proteomics (Cambridge University Press, Cambridge, 2006).
47. H. Hoffman, Kernel PCA for novelty detection. Pattern Recognit. 40, 863-874 (2007).
48. W. Chu, Z. Ghahramani, F. Falciani, D. L. Wild, Biomarker discovery in microarray gene expression data with Gaussian processes. Bioinformatics 21, 3385-3393 (2005).
49. J. M. Wang, D. J. Fleet, A. Hertzmann, Gaussian process dynamical models for human motion. IEEE Trans. Pattern Anal. Mach. Intell. 30, 283-298 (2008).
50. R. Urtasun, T. Darrell, Discriminative Gaussian process latent variable model for classification, in Proceedings of the 24th International Conference on Machine Learning, Corvallis, OR (ACM, New York, 2007), pp. 927-934.
51. M. Brunotto, A. M. Zarate, J. L. Barra, A. Malberti, Graph models for phenotype and genotype association between oral mucosa and submandibular gland tumorigenesis in rat. J. Oral Pathol. Med. 38, 463-469 (2009).
52. T. Grust, Current Trends in Database Technology - EDBT 2006: EDBT 2006 Workshops PhD, DataX, IIDB, IIHA, ICSNW, QLQP, PIM, PaRMA, and Reactivity on the Web, Munich, Germany, March 26-31, 2006: Revised Selected Papers (Springer, Berlin, 2006).
53. A. A. Desai, P. Hysi, J. G. Garcia, Integrating genomic and clinical medicine: Searching for susceptibility genes in complex lung diseases. Transl. Res. 151, 181-193 (2008).
54. J. P. Mathew, B. S. Taylor, G. D. Bader, S. Pyarajan, A. Antoniotti, A. M. Chinnaiyan, C. Sander, S. J. Burakoff, B. Mishra, From bytes to bedside: Data integration and computational biology for translational cancer research. PLoS Comput. Biol. 3, e12 (2007).
55. C. L. Chuang, K. Hung, C. M. Chen, G. S. Shieh, Uncovering transcriptional interactions via an adaptive fuzzy logic approach. BMC Bioinformatics 10, 400 (2009).
56. G. Chen, S. T. Jensen, C. J. Stoeckert Jr., Clustering of genes into regulons using integrated modeling-COGRIM. Genome Biol. 8, R4 (2007).
57. K. Lemmens, T. Dhollander, T. De Bie, P. Monsieurs, K. Engelen, B. Smets, J. Winderickx, B. De Moor, K. Marchal, Inferring transcriptional modules from ChIP-chip, motif and microarray data. Genome Biol. 7, R37 (2006).
58. H. Li, M. Zhan, Unraveling transcriptional regulatory programs by integrative analysis of microarray and transcription factor binding data. Bioinformatics 24, 1874-1880 (2008).
59. M. Dugas, C. Schoch, S. Schnittger, T. Haferlach, S. Danhauser-Riedl, W. Hiddemann, D. Messerer, K. Uberla, A comprehensive leukemia database: Integration of cytogenetics,molecular genetics and microarray data with clinical information, cytomorphology and immunophenotyping. Leukemia 15, 1805-1810 (2001).
60. A. Daemen, O. Gevaert, B. De Moor, Integration of clinical and microarray data with kernel methods. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2007, 5411-5415 (2007).
61. O. Gevaert, F. De Smet, D. Timmerman, Y. Moreau, B. De Moor, Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks. Bioinformatics 22, e184-e190 (2006).
62. D. Brammen, C. Katzer, R. Rohrig, K. Weismuller, M. Maier, H. Hossain, T. Menges, G. Hempelmann, T.Chakraborty, An Integrated Data-Warehouse-Concept for Clinical and Biological Information, in Connecting Medical Informatics and Bio-Informatics, R. Engelbrecht, A. Geissbuhler, C. Lovis, Eds. (IOS Press, Amsterdam, 2005).
63. E. Rahm, T. Kirsten, J. Lange, The GeWare data warehouse platform for the analysis of molecular-biological and clinical data. J. Integr. Bioinform. 4, 47-57 (2007).
64. C. Goble, R. Stevens, State of the nation in data integration for bioinformatics. J. Biomed. Inform. 41, 687-693 (2008).
65. N. F. Marko, R. A. Prayson, G. H. Barnett, R. J. Weil, Integrated molecular analysis suggests a three-class model for low-grade gliomas: A proof-of-concept study. Genomics 95, 16-24 (2010).
66. J. R. Nevins, E. S. Huang, H. Dressman, J. Pittman, A. T. Huang, M. West, Towards integrated clinico-genomic models for personalized medicine: Combining gene expression signatures and clinical factors in breast cancer outcomes prediction. Hum. Mol. Genet. 12 (Spec. No. 2), R153-R157 (2003).
67. S. M. Wang, L. L. Ooi, K. M. Hui, Identification and validation of a novel gene signature associated with the recurrence of human hepatocellular carcinoma. Clin. Cancer Res. 13, 6275-6283 (2007).
68. J. A. Cruz, D. S. Wishart, Applications of machine learning in cancer prediction and prognosis. Cancer Inform. 2, 59-77 (2007).
69. M. Pirooznia, J. Y. Yang, M. Q. Yang, Y. Deng, A comparative study of different machine learning methods on microarray gene expression data. BMC Genomics 9 (Suppl. 1), S13 (2008).
70. B. T. Greer, J. Khan, Diagnostic classification of cancer using DNA microarrays and artificial intelligence. Ann. N. Y. Acad. Sci. 1020, 49-66 (2004).
71. A. Narayanan, E. C. Keedwell, B. Olsson, Artificial intelligence techniques for bioinformatics. Appl. Bioinformatics 1, 191-222 (2002).
72. N. F. Marko, S. A. Toms, G. H. Barnett, R. Weil, Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: A preliminary feasibility study. Genomics 91, 395-406 (2008).
73. K. K. Nicodemus, J. D. Malley, Predictor correlation impacts machine learning algorithms: Implications for genomic studies. Bioinformatics 25, 1884-1890 (2009).
74. X. Y. Wu, Z. Y. Wu, K. Li, Identification of differential gene expression for microarray data using recursive random forest. Chin. Med. J. 121, 2492-2496 (2008).
75. T. Z. Tan, C. Quek, G. S. Ng, K. Razvi, Ovarian cancer diagnosis with complementary learning fuzzy neural network. Artif. Intell. Med. 43, 207-222 (2008).
76. S. C. Chow, M. Chang, Adaptive design methods in clinical trials - a review. Orphanet J. Rare Dis. 3, 11 (2008).
77. C. S. Coffey, J. A. Kairalla, Adaptive clinical trials: Progress and challenges. Drugs R. D. 9, 229-242 (2008).
78. H. Kitano, Violations of robustness trade-offs. Mol. Syst. Biol. 6, 384 (2010).
79. H. Kitano, Towards a theory of biological robustness. Mol. Syst. Biol. 3, 137 (2007).
80. Acknowledgments: We wish to thank the Melvin Burkhardt Chair in Neurosurgical Oncology and the Karen Colina Wilson research endowment within the Brain Tumor and Neuro- Oncology Center at the Cleveland Clinic Foundation for partial support and funding. Competing interests: The authors declare that they have no competing interests.